SHH and prostate carcinoma: Accordingly, this study evaluated the antiproliferative properties of bonediol in various lines of prostate cancer and also explored its effect on the Shh signaling pathway, interactions with the Nrf2 antioxidant response element, and potential binding to estrogen receptors (ERα and ERβ).